Web3 in the Pharmaceutical Industry

Research Overview

Author: Douglas Heintzman
Release Date: November 7, 2023

Abstract:

For decades, productivity and innovation in the pharmaceutical industry have declined. It has been slow to transform digitally and culturally. This research describes how executives can lead change by harnessing Web3 technologies. The payoffs will be greater internal rates of return on drug discovery and personalized medicine, and more efficient and secure clinical trials and supply chains among other significant benefits.

Related Content

Webinar: Blockchain and the Future of Digital Identity

Blockchain Research Institute Executive Chairman Don Tapscott moderated a panel discussion of digital identity—the self-sovereign identity, verifiable credentials, immunity passports, blockchain-based wallets, and more—featuring Brian Behlendorf, general manager for blockchain, healthcare, and identity at the Linux Foundation and executive director of Hyperledger; Stephen Curran, a principal of Cloud Compass Computing and a software developer and DevOps veteran; and Nathan George, senior director of engineering for the protocol team at Kiva Microfunds. This is an edited transcript of their candid conversation.

Read More

Can Blockchain Help with Gun Registries

Countries with universal background checks and gun registries experience significantly fewer gun-related deaths. As a highly encrypted, tamper-resistant, and decentralized database, distributed ledger technology has the potential to serve as a distributed registry of guns. DLT could allow gun buyers to prove a lack of a criminal record (the equivalent of a background check) without giving up personal information. This survey of the blockchain landscape highlights several start-ups such as VeriTransfer and BitRail that are experimenting with DLT to do for firearms provenance what other blockchain innovators have done with food, cannabis, and pharmaceuticals without impeding the rights of legitimate gun owners.

Read More
Subscribe